Viracta Therapeutics Inc. buy melinda
Start price
27.09.20
/
50%
€4.13
Target price
04.11.21
€8.75
Performance (%)
28.57%
End price
05.11.21
€5.31
Summary
This prediction ended on 05.11.21 with a price of €5.31. The prediction had a final performance of 28.57%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Viracta Therapeutics Inc. | 5.759% | 5.759% | -78.624% | -96.968% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by melinda for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
Buy mit Kursziel 2,5
In the thread Trading Sunesis Pharmaceuticals
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€52.50
04.04.19
04.04.19
€70.00
30.10.19
30.10.19
-63.33%
30.10.19
30.10.19
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.08
17.03.19
17.03.19
€52.50
04.04.19
04.04.19
102.68%
04.04.19
04.04.19
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€126.28
13.03.18
13.03.18
€232.04
13.09.18
13.09.18
-49.75%
13.09.18
13.09.18
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€767.97
30.09.13
30.09.13
€945.00
31.03.14
31.03.14
24.17%
31.03.14
31.03.14